IL15 and neoplasm: In regards to pancreatic cancer, it can be stated that the conduction of gene therapy by the usage of umbilical cord blood–isolated MSCs, transduced with the lentiviral vector that harbors IL-15 genes, can hinder tumor progression and prolong the survival time of tumor-bearing mice following systemic administration.